UPDATE: Cree (CREE) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Cree (CREE) PT Raised to $32 at BofA/Merrill Lynch; Remains Sidelined
October 18, 2017 9:50 AM EDTBofA/Merrill Lynch raised its price target on Cree (NASDAQ: CREE) to $32.00 (from $31.00) while maintaining a Neutral rating following the company's 1Q earnings report. Cree reported Sept quarter (F1Q18) revenue/Non-GAAP EPS of $360M/$0.04, in-line with consensus. Dec Q (F2Q18)... More
PacWest Bancorp (PACW) PT Lowered to $54 at Piper Jaffray; Reiterates Overweight
October 18, 2017 8:11 AM EDTPiper Jaffray lowered its price target on PacWest Bancorp (NASDAQ: PACW) to $54.00 (from $57.00) while maintaining a Overweight rating. Analyst Brett D. Rabatin trimmed FY17/18/19 estimates to $2.97/$3.25/$3.50 from $2.99/$3.37/$3.67. Lower NIM has again resulted in a more conservative forward estimate.
With... More



